| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |